Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 16]
Promoting competition key for high cost medicines
Tuesday, 8 April 2014, 11:12 am | PHARMAC
PHARMAC has announced its intention to test out a contestable fund for high cost medicines for rare disorders, which could be seeking proposals from pharmaceutical companies by the end of 2014. More >>
PHARMAC seeking public views on new decision criteria
Tuesday, 25 February 2014, 10:51 am | PHARMAC
PHARMAC is asking for people’s views on a proposed new framework for making pharmaceutical funding decisions. More >>
PHARMAC tender reveals vibrant market for pharmaceuticals
Wednesday, 12 February 2014, 10:46 am | PHARMAC
The number of companies bidding to be suppliers through the PHARMAC tender has grown to its largest size ever. PHARMAC runs a tender each year, asking pharmaceutical suppliers to provide pricing proposals for off-patent medicines listed on the Pharmaceutical ... More >>
Lung cancer treatment takes another forward step
Thursday, 9 January 2014, 8:50 am | PHARMAC
Improvements in lung cancer treatment are set to continue with a PHARMAC decision to extend funding for erlotinib (Tarceva) from 1 January 2014. More >>
Rotavirus, varicella vaccines added to national schedule
Tuesday, 17 December 2013, 11:44 am | PHARMAC
Rotavirus, varicella vaccines added to national immunisation schedule The addition of rotavirus vaccine to the list of funded vaccines will have a long-lasting positive effect on children’s health, says PHARMAC Medical Director Dr John Wyeth. PHARMAC ... More >>
PHARMAC declines eculizumab funding proposal due to price
Thursday, 12 December 2013, 2:41 pm | PHARMAC
An unreasonably high price means PHARMAC has decided not to approve funding for eculizumab, a treatment for the rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH). More >>
New agreement provides new medicines, saves millions
Monday, 9 December 2013, 3:25 pm | PHARMAC
A new agreement with GlaxoSmithKline (GSK) will see two newly listed medicines, improved access to commonly used asthma inhalers, and millions of dollars of savings. More >>
Funding for new drug to treat rare bleeding condition
Monday, 9 December 2013, 1:11 pm | PHARMAC
PHARMAC has agreed to fund a new drug to treat a rare and potentially fatal blood disorder. People with idiopathic thrombocytopenic purpura (ITP) have low numbers of the blood platelets that help with clotting. More >>
Medicine prescribing hits new high as PHARMAC role expands
Thursday, 5 December 2013, 11:26 am | PHARMAC
Medicine prescribing hits new high as PHARMAC role expands New Zealanders have gained greater access to medicines in 2013, and record numbers of New Zealanders received funded medicines in the past year. PHARMAC’s 2012/13 Annual Review, published today, ... More >>
PHARMAC proposing to add to national immunisation schedule
Thursday, 7 November 2013, 12:58 pm | PHARMAC
A vaccine for the gastric infection rotavirus and protection from varicella for the most vulnerable people are among proposed changes to the national immunisation schedule that PHARMAC is seeking feedback on. More >>
PHARMAC seeking input on hospital medical devices work
Friday, 18 October 2013, 10:05 am | PHARMAC
From cotton tips to MRI machines – a huge variety of medical devices are purchased by our hospitals to help diagnose and treat patients. Now PHARMAC is seeking further input as it decides how to apply its existing approach to managing hospital medical ... More >>
Influenza vaccine supply secured for next three years
Thursday, 17 October 2013, 11:14 am | PHARMAC
17 October, 2013 Influenza vaccine supply secured for next three years PHARMAC has secured the national supply of influenza vaccines for the next three years. Today PHARMAC announced that GSK and Abbott Pharmaceuticals will be the suppliers of influenza ... More >>
First funded treatment for motor neurone disease
Monday, 30 September 2013, 2:02 pm | PHARMAC
The first funded pharmaceutical treatment for Amyotrophic Lateral Sclerosis (ALS), the most common form of motor neurone disease, will become available from 1 October 2013. More >>
Easier access funded enzyme replacement therapy
Friday, 20 September 2013, 4:06 pm | PHARMAC
PHARMAC is providing greater funded access to the expensive enzyme replacement therapy imiglucerase (Cerezyme), mainly expanding its use in children. More >>
Genetic markers being used to target oral hepatitis C drug
Thursday, 22 August 2013, 10:55 am | PHARMAC
A person’s genetic makeup will be used to target a new funded oral treatment for hepatitis C patients from 1 September. More >>
100,000 people with new diabetes meters
Friday, 2 August 2013, 12:04 pm | PHARMAC
The change to new blood glucose testing meters has been completed, with more than 100,000 people picking up the new meters. More >>
Nationally-consistent hospital medicines takes effect
Monday, 1 July 2013, 9:36 am | PHARMAC
People will be able to get the same medicines whichever hospital they visit, thanks to a new Hospital Medicines List in place across the country from 1 July. More >>
Heart attack prevention takes a step forward
Sunday, 23 June 2013, 8:09 pm | PHARMAC
Treatment for the heart condition acute coronary syndrome (ACS) gets a boost from 1 July with funding for the new generation blood thinning drug ticagrelor (Brilinta) More >>
PHARMAC releases easy guide to funding applications
Tuesday, 16 April 2013, 2:05 pm | PHARMAC
PHARMAC has released new guidance for health professionals, consumers and clinicians to make it easier for them to apply for pharmaceuticals to be funded. Most funding applications come from pharmaceutical companies, although it has always been possible ... More >>
Significant step towards national hospital medicines list
Tuesday, 5 February 2013, 2:07 pm | PHARMAC
PHARMAC has taken a further major step towards forming a national list of hospital medicines that will be available nationwide. More >>
